[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Russell 2000 Stocks That Concern Us

3 Russell 2000 Stocks That Concern Us

TFIN : 75.93 (+2.84%)
BKU : 46.65 (+1.24%)
OCUL : 8.17 (-3.54%)
Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers

Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers

OCUL : 8.17 (-3.54%)
3 Cash-Burning Stocks with Open Questions

3 Cash-Burning Stocks with Open Questions

MSTR : 93.28 (-4.56%)
RDNT : 63.78 (+1.74%)
OCUL : 8.17 (-3.54%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 8.17 (-3.54%)
3 Small-Cap Stocks with Open Questions

3 Small-Cap Stocks with Open Questions

BCC : 76.38 (+1.33%)
TLYS : 3.81 (+2.70%)
OCUL : 8.17 (-3.54%)
Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences

BEDFORD, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced...

OCUL : 8.17 (-3.54%)
Ocular Therapeutix (OCUL): Buy, Sell, or Hold Post Q1 Earnings?

Ocular Therapeutix (OCUL): Buy, Sell, or Hold Post Q1 Earnings?

OCUL : 8.17 (-3.54%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., June 22, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 8.17 (-3.54%)
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos

Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos

MDLZ : 62.31 (-1.22%)
NU : 14.33 (-1.10%)
RMD : 210.98 (+1.16%)
SONO : 14.66 (+1.59%)
OCUL : 8.17 (-3.54%)
Why Ocular Therapeutix (OCUL) Stock Is Up Today

Why Ocular Therapeutix (OCUL) Stock Is Up Today

OCUL : 8.17 (-3.54%)

Barchart Exclusives

Meta’s Cash Engine Is Still Running Hot, Strengthening the Bull Thesis
Meta's Family of Apps generated $59.4 billion in advertising revenue during the second quarter, up 27% year-over-year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.